These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17548135)

  • 41. Dysfunctional labor: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Boatin AA; Eckert LO; Boulvain M; Grotegut C; Fisher BM; King J; Berg M; Adanu RMK; Reddy U; Waugh JJS; Gupta M; Kochhar S; Kenyon S;
    Vaccine; 2017 Dec; 35(48 Pt A):6538-6545. PubMed ID: 29150059
    [No Abstract]   [Full Text] [Related]  

  • 42. Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Sweet LR; Keech C; Klein NP; Marshall HS; Tagbo BN; Quine D; Kaur P; Tikhonov I; Nisar MI; Kochhar S; Muñoz FM;
    Vaccine; 2017 Dec; 35(48 Pt A):6506-6517. PubMed ID: 29150056
    [No Abstract]   [Full Text] [Related]  

  • 43. Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Rouse CE; Eckert LO; Babarinsa I; Fay E; Gupta M; Harrison MS; Kawai AT; Kharbanda EO; Kucuku M; Meller L; Mallett Moore T; Subelj M; Kochhar S; Tavares-Da-Silva F; ;
    Vaccine; 2017 Dec; 35(48 Pt A):6563-6574. PubMed ID: 29150062
    [No Abstract]   [Full Text] [Related]  

  • 44. Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Kachikis A; Eckert LO; Walker C; Oteng-Ntim E; Guggilla R; Gupta M; Patwardhan M; Mataya R; Mallett Moore T; Alguacil-Ramos AM; Keech C; Gravett M; Murphy H; Kochhar S; Chescheir N;
    Vaccine; 2017 Dec; 35(48 Pt A):6555-6562. PubMed ID: 29150061
    [No Abstract]   [Full Text] [Related]  

  • 45. Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Zanoni G; Girolomoni G; Bonetto C; Trotta F; Häusermann P; Opri R; Bonhoeffer J;
    Vaccine; 2016 Dec; 34(51):6561-6571. PubMed ID: 28029543
    [No Abstract]   [Full Text] [Related]  

  • 46. Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Easter SR; Eckert LO; Boghossian N; Spencer R; Oteng-Ntim E; Ioannou C; Patwardhan M; Harrison MS; Khalil A; Gravett M; Goldenberg R; McKelvey A; Gupta M; Pool V; Robson SC; Joshi J; Kochhar S; McElrath T;
    Vaccine; 2017 Dec; 35(48 Pt A):6546-6554. PubMed ID: 29150060
    [No Abstract]   [Full Text] [Related]  

  • 47. Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Carol Liu YC; Ibekwe T; Kelso JM; Klein NP; Shehu N; Steuerwald W; Aneja S; Dudley MZ; Garry R; Munoz FM;
    Vaccine; 2020 Jun; 38(30):4717-4731. PubMed ID: 32418788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
    Sell E; Munoz FM; Soe A; Wiznitzer M; Heath PT; Clarke ED; Spiegel H; Sawlwin D; Šubelj M; Tikhonov I; Mohammad K; Kochhar S;
    Vaccine; 2017 Dec; 35(48 Pt A):6501-6505. PubMed ID: 29150055
    [No Abstract]   [Full Text] [Related]  

  • 49. Safety assessment of immunization in pregnancy.
    Kochhar S; Bauwens J; Bonhoeffer J;
    Vaccine; 2017 Dec; 35(48 Pt A):6469-6471. PubMed ID: 29031696
    [No Abstract]   [Full Text] [Related]  

  • 50. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Collaborative improves monitoring of vaccine safety.
    Gearon CJ
    AHIP Cover; 2007; 48(5):16-8, 20, 22-4. PubMed ID: 17941571
    [No Abstract]   [Full Text] [Related]  

  • 52. Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Tavares Da Silva F; Gonik B; McMillan M; Keech C; Dellicour S; Bhange S; Tila M; Harper DM; Woods C; Kawai AT; Kochhar S; Munoz FM;
    Vaccine; 2016 Dec; 34(49):6057-6068. PubMed ID: 27431422
    [No Abstract]   [Full Text] [Related]  

  • 53. Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
    Schlaudecker EP; Munoz FM; Bardají A; Boghossian NS; Khalil A; Mousa H; Nesin M; Nisar MI; Pool V; Spiegel HML; Tapia MD; Kochhar S; Black S;
    Vaccine; 2017 Dec; 35(48 Pt A):6518-6528. PubMed ID: 29150057
    [No Abstract]   [Full Text] [Related]  

  • 54. Guidelines for good pharmacoepidemiology practices (GPP).
    Epstein M;
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):589-95. PubMed ID: 15918159
    [No Abstract]   [Full Text] [Related]  

  • 55. New book about vaccine safety.
    Offit PA
    Pediatrics; 2008 Oct; 122(4):871-2. PubMed ID: 18829814
    [No Abstract]   [Full Text] [Related]  

  • 56. Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    DeSilva M; Munoz FM; Mcmillan M; Kawai AT; Marshall H; Macartney KK; Joshi J; Oneko M; Rose AE; Dolk H; Trotta F; Spiegel H; Tomczyk S; Shrestha A; Kochhar S; Kharbanda EO;
    Vaccine; 2016 Dec; 34(49):6015-6026. PubMed ID: 27435386
    [No Abstract]   [Full Text] [Related]  

  • 57. Four initiatives proposed to improve safety reporting in clinical trials.
    J Support Oncol; 2004; 2(5):431-2. PubMed ID: 15524071
    [No Abstract]   [Full Text] [Related]  

  • 58. Detecting adverse drug reactions.
    Rosenbloom D; Wynne C
    CMAJ; 1999 Aug; 161(3):247-8. PubMed ID: 10463044
    [No Abstract]   [Full Text] [Related]  

  • 59. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Gershman MD; Staples JE; Bentsi-Enchill AD; Breugelmans JG; Brito GS; Camacho LA; Cottin P; Domingo C; Durbin A; Gascon J; Guenaneche F; Hayes EB; Jelenik Z; Khromava A; Martins Rde M; Wilson MM; Massy N; Nasidi A; Niedrig M; Sherwat A; Tsai T; Vilella A; Wilson ME; Kohl KS;
    Vaccine; 2012 Jul; 30(33):5038-58. PubMed ID: 22561144
    [No Abstract]   [Full Text] [Related]  

  • 60. Developing tools for the safety specification in risk management plans: lessons learned from a pilot project.
    Cooper AJ; Lettis S; Chapman CL; Evans SJ; Waller PC; Shakir S; Payvandi N; Murray AB
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):445-54. PubMed ID: 18383441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.